
Validea's Multi-Factor Investor model, leveraging Pim van Vliet's low-volatility investment strategy, rates Medtronic (MDT) at 81%, signaling strategic interest for this large-cap medical equipment and supplies stock. The model, which targets low volatility, strong momentum, and high net payout yields, found MDT passed on market cap and standard deviation, though it was neutral on momentum and net payout yield.
Medtronic (MDT) has received an 81% rating from Validea's Multi-Factor Investor model, a score which indicates strategic interest based on the low-risk investment framework of Pim van Vliet. The analysis confirms MDT's profile as a large-cap, low-volatility stock, as it passed the model's screens for both market capitalization and standard deviation. However, its performance on other key factors was less decisive, with the model assigning neutral ratings to MDT's "twelve minus one momentum" and its "net payout yield." This suggests that while the stock exhibits desirable stability, it may currently lack strong recent price appreciation and a compelling rate of capital return to shareholders. Critically, despite the positive attributes and the high interest score, the stock ultimately received a "FAIL" on the model's final rank, presenting a mixed signal for investors who are evaluating it strictly through this quantitative lens.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment